Schedule 13G ownership disclosure
HTG MOLECULAR DIAGNOSTICS IN
Security class unavailable · CUSIP: 40434H203
Event date: 2022-07-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.2260%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-22-042296
- Form type
- SC 13G
- Filer
- HTG MOLECULAR DIAGNOSTICS, INC
- CIK
- CIK 1169987
- Filed
- Jul 28, 2022
- Reporting period
- Jul 28, 2022
- Description
- Schedule 13G beneficial ownership